News & Insights | neurocare group

OCD: sleep could play key role in treatment outcome | neurocare group

Written by neurocare group | March 14, 2017 11:00:00 PM Z
Study at Brainclinics Research Institute suggests addressing sleep in OCD patients may improve response to rTMS

Brainclinics Research Institute recently presented first results from a study on rTMS in OCD patients at the Brain Stimulation Conference in Barcelona.

In this open-label study, 22 OCD patients received at least 10 sessions of rTMS combined with psychotherapy. The aim of the study is to compare sleep disturbances between OCD patients and healthy subjects, as well as between those who did and did not respond to rTMS treatment. Results showed that OCD patients had a higher rate of sleep disturbances than healthy subjects. Those who responded to rTMS treatment (55%)  showed significantly larger reduction in both obsessive-compulsive and depressive symptoms.

These results suggest that a predictive model based on circadian rhythm sleep disorder (CRSD) may be able to more accurately predict response to rTMS. This would point to a greater need to address circadian rhythm sleep disturbances in an OCD patient prior to rTMS treatment.

You can download the poster by Lana Donse here.

How is OCD treated?
Find out more about rTMS
Looking for treatment?
Find a neurocare clinic
Want to offer rTMS to your patients?
Find training workshops